Search

The European Commission’s current enquiry into competition in the pharmaceutical sector has generated opposition from the industry.

The leading Bulgarian think tank, the Applied Research and Communications Fund, has published its fifth annual innovation policy appraisal report.

The first 15 projects in the innovative medicines Joint Technology Initiative have been announced. The projects will receive a total of €246 million.

The League of European Research Universities (LERU) has appointed Professor Kurt Deketelaere as its new Secretary-General.

Nokia is to give away some of its intellectual property for free, in a scheme set up to recycle unused ideas and innovations to other Finnish companies.

Despite its €1.06 billion fine, Intel denies harming EU customers, and, as it opens its new R&D lab, says it remains committed to European R&D.

The UK is projected to have a £4 billion fall in R&D spend in 2009, according to a new report published by the Management Consultancies Association.

With investors keeping their money in their pockets, and the IPO window nailed shut, the 33 year-old model of biotech funding is outdated, says a new report.

It’s no great revelation that the biotech funding model is broken, yet the market for the industry’s drugs has never been greater. So where is the fix, asks Nuala Moran.

Whatever its shortcomings, FP7 has attracted a good response from researchers, says a progress report on its first two years.

The business angels network Oxford Investment Opportunity Network has enjoyed a record breaking time, investing £3.15 million in 15 companies.